Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Farma Nordic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3%   Bankruptcy risk   11.4% 9.6% 8.8% 5.9% 6.4% 6.9% 11.1% 11.1%   Credit score (0-100)   22 25 27 39 36 35 22 22   Credit rating   BB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -32.3 14.6 645 531 550 625 0.0 0.0   EBITDA   -32.3 14.6 570 107 269 238 0.0 0.0   EBIT   -32.3 14.6 570 107 269 238 0.0 0.0   Pre-tax profit (PTP)   -32.3 14.1 560.1 54.1 252.7 238.7 0.0 0.0   Net earnings   -32.3 14.1 438.4 34.8 196.4 183.8 0.0 0.0   Pre-tax profit without non-rec. items   -32.3 14.1 560 54.1 253 239 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   17.7 31.9 470 505 701 885 835 835   Interest-bearing liabilities   0.0 200 199 204 0.6 0.6 0.0 0.0   Balance sheet total (assets)   55.4 284 1,042 1,160 1,107 1,277 835 835   Net Debt   -33.9 38.6 -106 -678 -667 -778 -835 -835     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -32.3 14.6 645 531 550 625 0.0 0.0   Gross profit growth   0.0% 0.0% 4,329.2% -17.7% 3.7% 13.6% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   55 284 1,042 1,160 1,107 1,277 835 835   Balance sheet change%   0.0% 413.3% 266.4% 11.4% -4.6% 15.3% -34.6% 0.0%   Added value   -32.3 14.6 569.7 106.7 268.6 237.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 88.3% 20.1% 48.8% 38.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -58.3% 8.6% 86.4% 9.7% 24.8% 21.2% 0.0% 0.0%   ROI %   -182.3% 11.7% 127.1% 15.5% 39.9% 31.9% 0.0% 0.0%   ROE %   -182.3% 57.1% 174.6% 7.1% 32.6% 23.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   32.0% 11.2% 45.1% 43.5% 63.3% 69.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   104.9% 264.8% -18.7% -635.4% -248.3% -326.9% 0.0% 0.0%   Gearing %   0.0% 627.9% 42.3% 40.4% 0.1% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.4% 6.4% 26.1% 28.0% 2,495.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.5 0.9 1.8 1.4 2.7 2.9 0.0 0.0   Current Ratio   1.5 1.1 1.8 1.8 2.7 3.3 0.0 0.0   Cash and cash equivalent   33.9 161.4 305.4 882.1 667.5 778.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   17.7 31.9 470.3 505.0 701.4 885.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -32 15 570 107 269 238 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -32 15 570 107 269 238 0 0   EBIT / employee   -32 15 570 107 269 238 0 0   Net earnings / employee   -32 14 438 35 196 184 0 0